Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer Drugs Fund

Showing 15 posts of 53 posts found.

gilead-sciences

NICE approves first in new class of leukaemia drugs

September 24, 2015
Cancer Drugs Fund, Gilead Sciences, NHS, NICE, idelalisib, leukaemia, zydelig

NICE has issued final draft guidance which recommends that Gilead’s Zydelig should be made available on the NHS for some …

News
avastin_24

Cancer Drugs Fund ‘not sustainable in current form’

September 17, 2015
CDF, Cancer Drugs Fund, Department of Health, NHS England, National Audit Office, Public Accounts Committe, Roche, avastin

The Cancer Drugs Fund has improved access to treatments, although the UK still lags behind other countries despite its ‘unsustainable’ …

News

Counting the true cost of the Cancer Drugs Fund cuts

September 14, 2015
Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology

Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …

Feature
revlimid_celgene

Celgene threatens to scale back UK clinical trial investment after CDF snub

September 4, 2015
Research and Development, Sales and Marketing Cancer, Cancer Drugs Fund, Celgene, Revlimid, british nhs

One of the world’s leading pharma companies in oncology is considering whether to continue investing in clinical trials in the …

News
NHS sign

Companies braced for new round of cancer cuts

September 4, 2015
Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, cuts

Several treatments that extend the lives of people with cancer are expected to be removed from the Cancer Drugs Fund …

News
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015
Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …

News
Bayer image

Bayer wins Cancer Drugs Fund appeal

May 22, 2015
Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly

Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …

News

NHS backtracks on Cancer Drugs Fund de-listings

March 12, 2015
Sales and Marketing Afinitor, CDF, Cancer Drugs Fund, England, Halaven, NHS, Novartis, everolimus

NHS England is expected to perform a U-turn on several decisions to remove treatments from the cancer drugs fund when …

News

CDF chair: more treatment reviews to come

January 16, 2015
Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …

News

NHS drops 25 treatments from Cancer Drugs Fund

January 12, 2015
Sales and Marketing Afinitor, CDF, Cancer, Cancer Drugs Fund, Eisa, Halaven, Heribulin, Jevtana, NHS, Sanofi, Zaltrap, aflibercept, cabazitaxel, everolimus

Twenty-five cancer treatments will be removed from the Cancer Drugs Fund list, NHS England has announced. Having concluded its review …

News
cancer_drip_2

Remembering the patient in the Cancer Drugs Fund debate

September 5, 2014
Medical Communications, Sales and Marketing Beating Bowel Cancer, Cancer Drugs Fund, Kadclya, Roche

Today Simon is a bowel cancer patient who is able to enjoy his weekly round of golf.After receiving the dreadful …

News
david_cameron

Government rips up blank cheque on cancer drugs

August 28, 2014
Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi

Pharma has priced itself out of the Cancer Drugs Fund as the rising costs of its new oncology treatments sees …

News
Avastin packshot

UK pharma teams up for better cancer drug access

September 20, 2013
Medical Communications, Sales and Marketing Cancer Drugs Fund, NICE, Novartis, Roche, Sanofi, avastin, no

News
Halaven image

UK at centre of Eisai plans

September 18, 2012
Research and Development, Sales and Marketing CNS, Cancer Drugs Fund, Eisai, Fycompa, Halaven

Diseases of the central nervous system (CNS) and cancer will be the main areas targeted by Japanese firm Eisai as …

News
Avastin picture

Avastin now available in UK for ovarian cancer

January 17, 2012
Sales and Marketing Cancer, Cancer Drugs Fund, NICE, Roche, avastin

Roche’s Avastin is now available as a treatment for women with ovarian cancer in the UK. Avastin (bevacizumab) can now …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024